Glycorex Transplantation Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Johan Laven
Chief executive officer
kr52.5k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.3yrs |
CEO
Johan Laven (50 yo)
2.3yrs
Tenure
kr52,500
Compensation
Mr. Johan Lavén is Chief Executive Officer & Director of Glycorex Transplantation AB (publ) from 2022.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.3yrs | kr52.50k | no data | |
| Chairman of the Board | 1.3yrs | no data | no data | |
| Director | 28.3yrs | kr1.23m | 1.18% SEK 806.4k | |
| Deputy Director | 12.3yrs | no data | no data | |
| Director | 3.3yrs | kr92.50k | no data | |
| Director | 1.3yrs | no data | no data | |
| Director | 1.3yrs | no data | no data |
2.3yrs
Average Tenure
58yo
Average Age
Experienced Board: GTAB B's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.